Abstract: The present invention is directed to a method for inhibiting viral replication and treating viral infections by administering a pharmaceutically effective amount of a compound capable of binding a microtubule such as a diiodo thyronine analogue having no significant hormonal activity. The present invention also features novel pharmaceutical compositions comprising the same.
Abstract: The present invention relates to a protein having an anti-tumoral effect, a DNA encoding such a protein, and a process for the preparation of such a protein as well as its use.
Abstract: The present invention provides an AAV vector having a foreign DNA coding for a protein that boosts immunogenicity of cells. The invention also provides a vaccine containing such a vector and the use of both.
Type:
Grant
Filed:
May 5, 1999
Date of Patent:
January 9, 2001
Assignee:
Medigene AG
Inventors:
Gerhard Maass, Michael Hallek, Christoph Bogedain